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PURPOSE. To map the disease locus in a six-generation, consan-
guineous Pakistani family with autosomal recessive retinitis
pigmentosa (arRP). All affected individuals had pigmentary
retinopathy associated with symptoms of night blindness and
the loss of peripheral visual fields by the age of 20 years, loss
of central vision between the ages of 25 and 30 years, and
complete blindness between the ages of 40 and 50 years.
METHODS. Genomic DNA from family members was typed for
alleles at known polymorphic genetic markers using polymer-
ase chain reaction. Alleles were assigned to individuals, which
allowed calculation of LOD scores using the programs Cyrillic
(http://www.cyrillicsoftware.com) and MLINK (Cherwell Sci-
entific Publishing Ltd., Oxford, UK). The genes for membrane
glycoprotein (M6a) and chloride channel 3 (CLCN3) were
analyzed by direct sequencing for mutations.
RESULTS. A new locus for arRP (RP29) has been mapped to
chromosome 4q32-q34. A maximum two-point LOD score of
3.76 was obtained for the marker D4S415, with no recombi-
nation. Two recombination events in the pedigree positioned
this locus to a region flanked by markers D4S621 and D4S2417.
A putative region of homozygosity by descent was observed
between the loci D4S3035 and D4S2417, giving a probable
disease interval of 4.6 cM. Mutation screening of two candidate
genes, M6a and CLCN3, revealed no disease-associated muta-
tions.
CONCLUSIONS. The results suggest that the arRP phenotype maps
to a new locus and is due to a mutated gene within the
4q32-q34 chromosomal region. (Invest Ophthalmol Vis Sci.
2001;42:1436–1438)
Retinal photoreceptor dystrophies are a clinically and genet-ically heterogeneous group of retinal degenerations that
together form the most frequent cause of inherited visual
disorders, with an estimated prevalence of 1 in 4000.1,2 Reti-
nitis pigmentosa (RP) is characterized by progressive loss of
vision, initially manifesting as night blindness and reduction in
the peripheral visual field and later involving loss of central
vision.1 Ophthalmoscopic examination typically reveals pig-
mentary disturbances of the midperipheral retina. RP may be
inherited as an autosomal recessive, autosomal dominant, di-
genic, or X-linked trait. Autosomal recessive RP (arRP) ac-
counts for approximately 20% of all cases of RP, whereas
sporadic RP, which is presumed to be recessive in most cases,
accounts for a further 50%.2
To date, approximately 17 loci for arRP have been report-
ed.3 In this study we identified a novel locus for arRP (RP29)
on chromosome 4q32-q34.
METHODS
The study protocol adhered to the tenets of the Declaration of Helsinki.
We studied 16 members of a six-generation, consanguineous Pakistani
family in which RP segregated as an autosomal recessive trait (Fig. 1).
This pedigree contained six affected individuals in two branches.
Fundus examination of all affected individuals revealed the typical
clinical features of retinitis pigmentosa, including pigment deposition,
attenuation of blood vessels, and pallid disc. The peripheral blood
vessels were completely obliterated in individuals V:3, V:6, and VI:7
(Fig. 1). The early stage of the disease was clinically characterized by
bone corpuscle–type pigmentation, deposited mainly in the equatorial
region, and macular involvement in the later stages of the disease.
Affected subjects experienced night blindness from the age of approx-
imately 20 years and deterioration of visual acuity (central vision)
between 25 and 30 years of age. By the age of 40 to 50 years affected
subjects had no perception of light in either eye. Biomicroscopy
showed the presence of cells in vitreous of individuals V:7 and VI:4.
Anterior polar and posterior capsular lens opacities were also observed
in individuals V:3 and V:6 (Fig. 1). Subjects were designated as unaf-
fected if they showed no clinical evidence of RP by the age of 30 years.
DNA Extraction
Peripheral blood samples were collected with informed consent from
the affected and unaffected members of the family (Fig. 1). For com-
parison, 100 ethnically matched individuals with no personal or family
history of retinopathy were selected to serve as control subjects.
Genomic DNA was extracted from whole blood using an extraction kit
(Nucleon II; Scotlab Bioscience, Strathclyde, Scotland, UK).
Microsatellite and Linkage Analysis
Genomic DNA from family members was amplified by using primers
for microsatellite markers for the known arRP loci3 and whole-genome
search4 by polymerase chain reaction (PCR). PCR products were sep-
arated by nondenaturing polyacrylamide gel electrophoresis (Protogel;
National Diagnostics, Manville, NJ) and visualized under UV illumina-
tion after staining with ethidium bromide. Alleles were assigned to
individuals, and genotypic data were used to calculate the LOD scores
using the programs Cyrillic and MLINK. Allele frequencies were calcu-
lated from the spouses in this family and a control ethnically matched
population. The phenotype was analyzed as an autosomal recessive
trait, with complete penetrance, and a frequency of 0.0001 for the
affected allele.
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Mutation Screening
Intronic forward and reverse primers were designed for the exons of
the candidate genes. The PCR reactions (25 or 50 ml) were performed
using DNA samples of unaffected parents for heteroduplex analysis
under standard conditions with Taq DNA polymerase (Bio-Line; Lon-
don, UK). Annealing was at the exon-specific temperature. To identify
any heteroduplexes, the amplified exons were analyzed by electro-
phoresis using MDE gel (FMC, Rockland, ME).5 The gels were run at
180 V overnight on a commercial apparatus (model 600S; Hoefer, San
Francisco, CA). Products of PCR amplification were sequenced using a
commercially available kit (Prism Ready Reaction Sequencing Kit; Per-
kin Elmer–ABI, Warrington, UK), and the products were analyzed on
an automated sequencer (model 377; Perkin Elmer–ABI). All PCR
products were sequenced in the forward and reverse directions.
RESULTS
Linkage analysis was performed on this family as described
earlier. The known arRP loci3 were tested for linkage to the
disease in this family using two microsatellite markers centered
on the critical region of each locus. Linkage to any of the
known arRP loci was not observed.
A genome-wide search was undertaken using 300 polymor-
phic markers spanning the entire human genome at approxi-
mately 20-cM intervals (Research Genetics, Huntsville, AL).
Significant exclusion was obtained for all markers except those
located on chromosome 4q32-q34. Haplotypes for these
markers are shown in Figure 1. Two-point LOD scores between
arRP and the markers in this region (D4S1629, D4S2368,
D4S2979, D4S621, D4S2431, D4S3028, D4S3035, D4S3030,
D4S415, and D4S2417) are summarized in Table 1. The maxi-
mum LOD score of 3.76 was obtained for the marker D4S415.
A positive LOD score of 3.48 at u 5 0.00 was also obtained
with D4S3030. Recombination events involving markers
D4S621 in individual V:3 and D4S2417 in individuals V:6 and
VI:6 define the centromeric and telomeric boundaries, respec-
tively, of the 6-cM5 disease locus between these markers (Fig.
1). Because this was a consanguineous family, a region of
homozygosity would be expected to surround the associated
gene. All the patients in both branches of this family were
homozygous for alleles of the microsatellites D4S3030 and
D4S415. This most probably indicates an area of homozygosity
by descent, and it is therefore probable that the disease gene
lies in this smaller interval, flanked by the markers D4S3035
FIGURE 1. Pedigree of an arRP family with analysis of genotypic data for microsatellite markers. Circles: women; squares: men; filled symbols:
affected individuals; open symbols: unaffected individuals. Double line connecting the spouses represents consanguinity.
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and D4S2417. This interval spans only 4.6 cM (Fig. 1). These
results have permitted us to identify a novel locus for arRP
(RP29) at 4q32-q34. The locus does not overlap any previously
identified retinal dystrophy locus; therefore, this represents the
identification of a novel locus for a gene that could be impor-
tant for normal retinal functioning. This 18th autosomal reces-
sive locus illustrates genetic heterogeneity of the arRP pheno-
type.
The genetic databases6–8 were searched to identify the
candidate gene(s) in the region. The genes M6a and CLCN3,
which were physically mapped within the disease region, were
analyzed for mutation by heteroduplex analysis and direct
sequencing. All the exons were amplified using primers de-
signed for the intronic regions of the genes to permit detection
of any splice site mutations. M6a is a cell surface glycoprotein,
mainly expressed on neurons in the murine central nervous
system (CNS), which plays significant roles in neural cell ad-
hesion and some aspects of neurite growth.9–11 CLCN3 is a
member of the voltage-gated chloride channel family and is
expressed primarily in tissues derived from the neuroecto-
derm.12
Sequencing of both these genes revealed no disease-associ-
ated mutations. However, a T3G substitution was found in
the noncoding region of exon 5 at nucleotide 1307 of the M6a
gene.10 No disease-associated segregation for this change was
observed.
DISCUSSION
Examination of the GeneMap’996 and analysis of the genomic
sequence available from this region did not identify any candi-
dates in addition to the two we have screened. The genomic
sequencing of the region is unfinished as yet, and, in addition,
many gaps remain that could explain the lack of identifiable
candidates. Further isolation and characterization of novel tran-
scripts from this region will aid the identification of this disease
gene. Further effort is required to identify the disease-causing
gene in this region of chromosome 4q, which is syntenic with
a region of mouse chromosome 8. There are, however, no
reports of a mouse model with retinal degeneration mapping
to this locus.
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TABLE 1. Two-Point LOD Score Data of an arRP Family for Chromosome 4q Microsatellite Markers
Marker
Recombination Fraction
0.0 0.01 0.05 0.1 0.2 0.3 0.4 Zmax umax
D4S1629 ‘ 21.54 20.32 0.08 0.25 0.18 0.06 0.25 0.2
D4S2368 ‘ 0.13 1.21 1.41 1.19 0.72 0.24 1.21 0.05
D4S2979 22.89 20.14 0.98 1.25 1.14 0.72 0.24 1.25 0.1
D4S621 ‘ 1.61 2.04 1.99 1.56 0.98 0.39 2.04 0.05
D4S2431 0.72 2.13 2.52 2.44 1.89 1.15 0.39 2.52 0.05
D4S3028 20.55 0.87 1.33 1.33 1.02 0.58 0.15 1.33 0.05
D4S3035 20.54 0.89 1.35 1.37 1.08 0.65 0.22 1.37 0.1
D4S3030 3.48 3.41 3.13 2.76 2.00 1.21 0.46 3.48 0.0
D4S415 3.76 3.68 3.36 2.95 2.09 1.20 0.38 3.76 0.0
D4S2417 ‘ 20.91 0.24 0.53 0.53 0.33 0.12 0.53 0.1
Zmax, maximum LOD score; umax, recombination fraction of Zmax. Line in bold indicates the marker with maximum LOD score.
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